SLS CIK: 1390478

SELLAS Life Sciences Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.40
FY22:
0.90
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−25.3
FY22:
−42.0
FY23:
−37.9
FY24:
−31.5
FY25:
−28.3
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−37.9
FY24:
−31.5
FY25:
−28.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.9
FY22:
−41.3
FY23:
−37.3
FY24:
−30.9
FY25:
−26.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.7
FY22:
−41.3
FY23:
−37.3
FY24:
−30.9
FY25:
−26.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data